High-throughput screening identifies proteasome inhibition as promising strategy for treatment of ALK-mutant neuroblastoma

An article created on 2026-10-19 17:42:27

#	Наименование новости	Информативность	Дата публикации
1	A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma	13.31	20-10-2026
2	Cross-Platform Evaluation of a Locked Two-Pathway Transcriptomic Score for Early Mortality in Diffuse Large B-Cell Lymphoma	28.18	19-10-2026
3	Resistance of breast cancer stem cells to TROP2-targeted CAR-T therapy via the NF-κB signaling pathway	29.05	20-10-2026
4	Characterization of IKBIP prognostic values in collaboration with immune infiltrates in glioma	14.17	19-10-2026
5	Intratumoral influenza A virus infection drives platinum resistance and invasive reprogramming in NSCLC	15.26	21-10-2026
6	Successful Renal Artery Stenting in an Infant With Middle Aortic Syndrome: Resolution of Malignant Hypertension and Normalization of Renal Growth	11.19	19-10-2026
7	Identification of Plasma LGALS3BP via Proteomics and Development of a Non-invasive Diagnostic Model for Early-Stage Lung Adenocarcinoma	25.78	19-08-2026
8	Allogeneic HSCT Improves Prognosis in Advanced Extranodal NK/T-Cell Lymphoma	23.33	19-08-2026
9	The Role of Alveolar Pneumocytes in the Lung Microenvironment of Osteosarcoma Metastases	12.84	19-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 25.79. Источник: www.researchsquare.com.

Найдите то, что Вас интересует